Protective effects of pretreatment with Ginsenosides on cardiac and coronary vascular function after hypothermic rat heart preservation

Hiroshima Journal of Medical Sciences

Volumn 48, Issue 2, 1999, Pages 65-70

  Zhang, Jie Min ^a   Matsuura, Yuichiro ^a   Sueda, Taijiro ^a   Orihashi, Kazumasa ^a   Fukunaga, Shintaro ^b   Watari, Masanobu ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

Ginsenosides; Heart preservation; Langendorff perfusion; Reperfusion damage

Indexed keywords

ACETYLCHOLINE; GINSENOSIDE; GLYCERYL TRINITRATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY BLOOD VESSEL; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART PRESERVATION; HEART PROTECTION; HEART TRANSPLANTATION; HYPOTHERMIA; MALE; NONHUMAN; RAT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; WATER CONTENT;

ANIMALS; COLD; CORONARY VESSELS; GINSENOSIDES; HEART; MALE; MYOCARDIUM; ORGAN PRESERVATION; RATS; RATS, WISTAR; SAPONINS; VASODILATOR AGENTS; WATER;

EID: 0032769671     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bath, P.M.W., Hassall, D.G., Gladwin, A-M., Palmer, R.M.J. and Martin, J.F. 1991. Nitric oxide and prostacyclin: divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb. 11: 254-260.
2. Bolling, S.F., Su, T.P., Childs, K.F., Nhig, X.H., Horton, N., Kilgore, K. and Oeltgen, P.R. 1997. The use of hibernation induction triggers for cardiac transplant preservation. Transplantation 63: 326-329.
3. Cartier, R., Dagenais, F., Hollmann, C., Carrier, M. and Pelletier, L.C. 1993. The role of preservation solution in coronary endothelial damage during cold storage. Transplantation 46: 87-91.
4. Chen, X. and Fang, Y-X. 1987. Experimental study of Ginsenosides on myocardial ischemia and reperfusion injury. Natl. Med. J. China 67: 581-583.
5. Chen, X. 1996. Cardiovascular protection by Ginsenosides and their nitric oxide relaxing action. Clin-Exp-Pharmacol-Physiol. 23: 728-732.
6. Chen, X. and Gillis, C.N. 1991. Effect of free radical on pulmonary vascular response to acetylcholine. J.H. Appl. Physiol. 71: 821-825.
7. Cooke, J.P. and Tsao, P.S. 1993. Cytoprotective effects of nitric oxide. Circulation 88: 2451-2454.
8. Demertzis, S., Wippermann, J., Schaper, J., Wahlers, T., Schafers, H.J., Wagenbreth, I., Hausen, B. and Haverich, A. 1993. University of Wisconsin versus St. Thomas' Hospital solution for human donor heart preservation. Ann. Thorac. Surg. 55: 1131-1137.
9. Duguay, P., Chen, H., Daloze, P. and Dumont, L. 1996. Cardioprotective effects of the lazaroid U74389G following cold preservation and transplantation of rat hearts. Transplantation 61: 1023-1028.
10. 2 by Ginsenosides in myocardial infarction and reperfusion injury of dogs. Acta. Pharmacol. Sin. 7: 222-226.
11. Gillis, C.N. 1997. Panax ginseng pharmacology: A nitric oxide link? Biochem. Pharmacol. 54: 1-8.
12. Jeevanadam, V., Barr, M.L., Auteri, J.S., Sanchez, J.A., Fong, J., Schenkel, F.A., Marboe, C.C., Michler, R.E., Smith, C.R. and Rose, E.A. 1992. University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trail. J. Thorac. Cardiovasc. Surg. 103: 194-199.
13. Kang, S.Y., Schini-Kerth, V.B. and Kim, N.D. 1995. Ginsenosides of propanaxatraol group cause endothelium-dependent relaxation in the rat aorta. Life Sci. 56: 1577-1586.
14. Kim, H., Chen, X. and Gillis, C.N. 1992. Ginsenosides protect pulmonary vascular endothelium against free radical-induced injury. Biochem. Biophys. Res. Commun. 189: 670-676.
15. Kim, N.D., Kang, S.Y. and Schini, V.B. 1994. Ginsenosides evoke endothelium-dependent vascular relaxation in rat aorta. Gen. Pharmacol. 25: 1071-1077.
16. Kubes, P., Suzuki, M. and Granger, D.N. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88: 4651-4655.
17. Kusuoka, H. and Marban, E. 1992. Cellular mechanisms of myocardial stunning. Ann. Rev. Physiol. 54: 243-256.
18. Lefer, A.M. and Lefer, D.J. 1993. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Ann. Rev. Pharmacol. Toxicol. 33: 71-90.
19. Mankad, P.S., Chester, A.H. and Yacoub, M.H. 1991. Role of potassium concentration in cardioplegia solution in mediating endothelial damage. Ann. Thorac. Surg. 51: 89-93.
20. Murphy, C.O., Pan-Chih, Gott, J.P. and Guyton, R.A. 1995. Microvascular reactivity after crystalloid, cold blood, and warm blood cardioplegic arrest. Ann. Thorac. Surg. 60: 1021-1027.
21. Nishida, T., Morita, S., Miyamoto, K., Masuda, M., Tominaga, R., Kawachi, Y. and Yasui, H. 1996. Lazaroid (U74500A) Prevents Vascular and Myocardial Dysfunction After 24-Hour Heart Preservation. A study Based on Cross-Circulated Blood-perfused Rabbit Hearts. Circulation 94 (suppl II): II326-331.
22. Opie, L.H. 1989. Reperfusion injury and its pharmacologic modification. Circulation 80: 1049-1062.
23. Pohl, U. and Busse, R. 1989. EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed. Circ. Res. 65: 1798-1803.
24. Radomski, M.W., Palmer, R.M.J. and Moncada, S. 1987. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol. 92: 181.
25. Rimar, S. and Gillis, C.N. 1997. Nitric oxide and experimental lung injury, p. 165-183. In W.M. Zapol and K.D. Bloch (eds.), Nitric Oxide and the Lung. Marcel Dekker, New York.
26. Sellke, F.W., Shafique, T., Schoen, F.J. and Weintraub, R.M. 1993. Impaired endothelium-dependent coronary microvascular relaxation after cold potassium cardioplegia and reperfusion. J. Thorac. Cardiovasc. Surg. 105: 52-58.
27. Shibata, S., Tanaka, O., Shoji, J. and Saito, H. 1985. Chemistry and pharmacology of Panax, p. 217-284. In H. Wagner, H. Hikino and N.R. Farnsworrh (eds.), Economic and Medicinal Plant Research. Vol. 1. Academic Press, New York.
28. Shibata, S., Tanaka, O., Soma, K., Iida, Y. and Namamura, H. 1965. Studies on saponins and sapogins of ginseng. Tetrahedron Lett. 3: 207-213.
29. Shimokawa, H., Aarhus, L.L. and Vanhoutte, P.M. 1987. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ. Res. 61: 711-716.
30. Soldati, F. and Sticher, O. 1980. HPLC separation and quantitative determination of ginsenosides from Panax ginseng, Panax quinquefolium and from ginseng drug preparations. Planta. Med. 39: 348-357.
31. Stamler, J.S., Mendelsohn, M.E., Amarante, P., Smick, D., Andon, N., Davies, P.F., Cooke, J.P. and Loscalzo, J. 1989. N-Acetylcysteinepotentiates platelet inhibition by endothelium-derived relaxing factor. Circ. Res. 65: 789-795.
32. Stein, D.G., Drinkwater, D.C., Laks, H., Permut, L.C., Sangwan, S., Chait, H.I., Child, J.S. and Bhuta, S. 1991. Cardiac preservation in patients undergoing transplantation. A clinical trail comparing University of Wisconsin solution and Stanford solution. J. Thorac. Cardiovasc. Surg. 102: 657-665.
33. Williams, R.E., Zweier, J.L. and Flaherty, J.T. 1991. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation 83: 1006-1014.
34. Yang, B.C., Li, Y.J. and Chen, X. 1989. Correlation between protective effect of Ginsenosides against myocardial ischemia and lipid peroxidation in rats. Asian Pac. J. Pharmacol. 4: 265-272.
35. Zhan, Y., Xu, X.H. and Jiang, Y.P. 1994. Effects of Ginsenosides on myocardial ischemia/reperfusion damage in open-heart surgery patients. Med. J. China 74: 626-628.
36. Zhang, J.M., Zhao, H.X., Song, X.L., Wang, Y., Jiang, D.W., Wang, X.P. and Xuan, W.G. 1990. Study on the Effects of Ginsenosides on Global Ischemia/Reperfusion Damage. Chinese Journal of Thoracic and Cardiovascular Surgery 6 (Supplement): 105-108.
37. Zimmerman, B.J. and Granger, D.N. 1992. Reperfusion injury. Surg. Clin. North. Am. 72: 65-83.